Focal adhesion kinase (FAK) expression in normal and neoplastic lymphoid tissues

Pathology Research and Practice

Volumn 205, Issue 11, 2009, Pages 781-788

  Ozkal, Sermin ^a   Paterson, Jennifer C ^a   Tedoldi, Sara ^a   Hansmann, Martin Leo ^b   Kargi, Aydanur ^c   Manek, Sanjiv ^d   Mason, David Y ^a   Marafioti, Teresa ^a  

^a Leukaemia Research Fund Immunodiagnostics Unit   (United Kingdom)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c DOKUZ EYLUL UNIVERSITY   (Turkey)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Focal adhesion kinase; Immunohistochemistry; Lymphoid tissue; Lymphoma

Indexed keywords

ANTIBODY; FOCAL ADHESION KINASE; TUMOR MARKER;

ARTICLE; B CELL LYMPHOMA; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; GERMINAL CENTER; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHATIC LEUKEMIA; LYMPHATIC SYSTEM TUMOR; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; T CELL LYMPHOMA; TISSUE DISTRIBUTION;

CHI-SQUARE DISTRIBUTION; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES; LYMPHOID TISSUE; LYMPHOMA;

EID: 71749113774     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2009.07.002     Document Type: Article

References (47)

1. Abbi S., Ueda H., Zheng C., Cooper L.A., Zhao J., Christopher R., and Guan J.L. Regulation of focal adhesion kinase by a novel protein inhibitor FIP200. Mol. Biol. Cell 13 (2002) 3178-3191
2. Astier A., Avraham H., Manie S.N., Groopman J., Canty T., Avraham S., and Freedman A.S. The related adhesion focal tyrosine kinase is tyrosine-phosphorylated after beta1-integrin stimulation in B cells and binds to p130cas. J. Biol. Chem. 272 (1997) 228-232
3. Ayaki M., Komatsu K., Mukai M., Murata K., Kameyama M., Ishiguro S., Miyoshi J., Tatsuta M., and Nakamura H. Reduced expression of focal adhesion kinase in liver metastases compared with matched primary human colorectal adenocarcinomas. Clin. Cancer Res. 7 (2001) 3106-3112
4. Benlimame N., He Q., Jie S., Xiao D., Xu Y.J., Loignon M., Schlaepfer D.D., and Alaoui-Jamali M.A. FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion. J. Cell Biol. 171 (2005) 505-516
5. Berg N.N., and Ostergaard H.L. T cell receptor engagement induces tyrosine phosphorylation of FAK and Pyk2 and their association with Lck. J. Immunol. 159 (1997) 1753-1757
6. L. Cai, J. Han, X. Zhuo, Y. Xiong, J. Dong, X. Li, Overexpression and significance of focal adhesion kinase in hepatocellular carcinoma and its relationship with HBV infection. Med. Oncol. 2008 (November 20) (Epub ahead of print).
7. Cance W.G., Harris J.E., Iacocca M.V., Roche E., Yang X., Chang J., Simkins S., and Xu L. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Clin. Cancer Res. 6 (2000) 2417-2423
8. Canel M., Secades P., Rodrigo J.P., Cabanillas R., Herrero A., Suarez C., and Chiara M.D. Overexpression of focal adhesion kinase in head and neck squamous cell carcinoma is independent of fak gene copy number. Clin. Cancer Res. 12 (2006) 3272-3279
9. Cohen L.A., and Guan J.L. Mechanisms of focal adhesion kinase regulation. Curr. Cancer Drug Targets 5 (2005) 629-643
10. Cox B.D., Natarajan M., Stettner M.R., and Gladson C.L. New concepts regarding focal adhesion kinase promotion of cell migration and proliferation. J. Cell. Biochem. 99 (2006) 35-52
11. Duxbury M.S., Ito H., Benoit E., Zinner M.J., Ashley S.W., and Whang E.E. RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity. Biochem. Biophys. Res. Commun. 311 (2003) 786-792
12. Furuyama K., Doi R., Mori T., Toyoda E., Ito D., Kami K., Koizumi M., Kida A., Kawaguchi Y., and Fujimoto K. Clinical significance of focal adhesion kinase in resectable pancreatic cancer. World J. Surg. 30 (2006) 219-226
13. Gabriel B., zur Hausen A., Stickeler E., Dietz C., Gitsch G., Fisher D.C., Bouda J., Tempfer C., and Hasenburg A. Weak expression of focal adhesion kinase (pp125FAK) in patients with cervical cancer is associated with poor disease outcome. Clin. Cancer Res. 12 (2006) 2476-2483
14. Gilmore A.P., and Romer L.H. Inhibition of focal adhesion kinase (FAK) signaling in focal adhesions decreases cell motility and proliferation. Mol. Biol. Cell 7 (1996) 1209-1224
15. Gutenberg A., Bruck W., Buchfelder M., and Ludwig H.C. Expression of tyrosine kinases FAK and Pyk2 in 331 human astrocytomas. Acta. Neuropathol. (Berl.) 108 (2004) 224-230
16. Halder J., Lin Y.G., Merritt W.M., Spannuth W.A., Nick A.M., Honda T., Kamat A.A., Han L.Y., Kim T.J., Lu C., Tari A.M., Bornmann W., Fernandez A., Lopez-Berestein G., and Sood A.K. Therapeutic efficacy of a novel Focal Adhesion Kinase Inhibitor TAE226 in ovarian carcinoma. Cancer Res. 67 (2007) 10976-10983
17. Hsia D.A., Lim S.T., Bernard-Trifilo J.A., Mitra S.K., Tanaka S., den Hertog J., Streblow D.N., Ilic D., Ginsberg M.H., and Schlaepfer D.D. Integrin alpha4beta1 promotes focal adhesion kinase-independent cell motility via alpha4 cytoplasmic domain-specific activation of c-Src. Mol. Cell. Biol. 25 (2005) 9700-9712
18. Hsia D.A., Mitra S.K., Hauck C.R., Streblow D.N., Nelson J.A., Ilic D., Huang S., Li E., Nemerow G.R., Leng J., Spencer K.S., Cheresh D.A., and Schlaepfer D.D. Differential regulation of cell motility and invasion by FAK. J. Cell Biol. 160 (2003) 753-767
19. Itoh S., Maeda T., Shimada M., Aishima S., Shirabe K., Tanaka S., and Maehara Y. Role of expression of focal adhesion kinase in progression of hepatocellular carcinoma. Clin. Cancer Res. 10 (2004) 2812-2817
20. Swerdlow S.H., Campo E., Haris N.L., Jaffe E.S., Pileri S.A., Stein H., Thiele J., and Vardiman J.W. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. fourth ed. (2008), IARC Press, Lyon
21. Jarvis L.J., Maguire J.E., and LeBien T.W. Contact between human bone marrow stromal cells and B lymphocytes enhances very late antigen-4/vascular cell adhesion molecule-1-independent tyrosine phosphorylation of focal adhesion kinase, paxillin, and ERK2 in stromal cells. Blood 90 (1997) 1626-1635
22. Kanner S.B., Aruffo A., and Chan P.Y. Lymphocyte antigen receptor activation of a focal adhesion kinase-related tyrosine kinase substrate. Proc. Natl. Acad. Sci. USA 91 (1994) 10484-10487
23. Kim S.J., Park J.W., Yoon J.S., Mok J.O., Kim Y.J., Park H.K., Kim C.H., Byun D.W., Lee Y.J., Jin S.Y., Suh K.I., and Yoo M.H. Increased expression of focal adhesion kinase in thyroid cancer: immunohistochemical study. J. Korean Med. Sci. 19 (2004) 710-715
24. Kurenova E., Xu L.H., Yang X., Baldwin Jr. A.S., Craven R.J., Hanks S.K., Liu Z.G., and Cance W.G. Focal adhesion kinase suppresses apoptosis by binding to the death domain of receptor-interacting protein. Mol. Cell. Biol. 24 (2004) 4361-4371
25. Lacoste J., Aprikian A.G., and Chevalier S. Focal adhesion kinase is required for bombesin-induced prostate cancer cell motility. Mol. Cell Endocrinol. 235 (2005) 51-61
26. Lark A.L., Livasy C.A., Calvo B., Caskey L., Moore D.T., Yang X., and Cance W.G. Overexpression of focal adhesion kinase in primary colorectal carcinomas and colorectal liver metastases: immunohistochemistry and real-time PCR analyses. Clin. Cancer Res. 9 (2003) 215-222
27. Lightfoot Jr. H.M., Lark A., Livasy C.A., Moore D.T., Cowan D., Dressler L., Craven R.J., and Cance W.G. Upregulation of focal adhesion kinase (FAK) expression in ductal carcinoma in situ (DCIS) is an early event in breast tumorigenesis. Breast Cancer Res. Treat. 88 (2004) 109-116
28. Liu W., Bloom D.A., Cance W.G., Kurenova E.V., Golubovskaya V.M., and Hochwald S.N. FAK and IGF-IR interact to provide survival signals in human pancreatic adenocarcinoma cells. Carcinogenesis 29 (2008) 1096-1107
29. Liu J., and Waalkes M. Focal adhesion kinase as a potential target in arsenic toxicity. Toxicol. Sci. 84 (2005) 212-213
30. Ma E.A., Lou O., Berg N.N., and Ostergaard H.L. Cytotoxic T lymphocytes express a beta3 integrin which can induce the phosphorylation of focal adhesion kinase and the related PYK-2. Eur. J. Immunol. 27 (1997) 329-335
31. Manie S.N., Astier A., Wang D., Phifer J.S., Chen J., Lazarovits A.I., Morimoto C., and Freedman A.S. Stimulation of tyrosine phosphorylation after ligation of beta7 and beta1 integrins on human B cells. Blood 87 (1996) 1855-1861
32. McLean G.W., Carragher N.O., Avizienyte E., Evans J., Brunton V.G., and Frame M.C. The role of focal-adhesion kinase in cancer - a new therapeutic opportunity. Nat. Rev. Cancer 5 (2005) 505-515
33. Mitra S.K., Hanson D.A., and Schlaepfer D.D. Focal adhesion kinase: in command and control of cell motility. Nat. Rev. Mol. Cell Biol. 6 (2005) 56-68
34. Miyazaki T., Kato H., Nakajima M., Sohda M., Fukai Y., Matsuda N., Manda R., Fukuchi M., Tsukada K., and Kuwano H. FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma. Br. J. Cancer 89 (2003) 140-145
35. Mlinaric-Rascan I., and Yamamoto T. B cell receptor signaling involves physical and functional association of FAK with Lyn and IgM. FEBS Lett. 498 (2001) 26-31
36. Oktay M.H., Oktay K., Hamele-Bena D., Buyuk A., and Koss L.G. Focal adhesion kinase as a marker of malignant phenotype in breast and cervical carcinomas. Hum. Pathol. 34 (2003) 240-245
37. Owens L.V., Xu L., Dent G.A., Yang X., Sturge G.C., Craven R.J., and Cance W.G. Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer. Ann. Surg. Oncol. 3 (1996) 100-105
38. Parsons J.T. Focal adhesion kinase: the first ten years. J. Cell Sci. 116 (2003) 1409-1416
39. Parsons J.T., Martin K.H., Slack J.K., Taylor J.M., and Weed S.A. Focal adhesion kinase: a regulator of focal adhesion dynamics and cell movement. Oncogene 19 (2000) 5606-5613
40. Reddig P.J., and Juliano R.L. Clinging to life: cell to matrix adhesion and cell survival. Cancer Metastasis Rev. 24 (2005) 425-439
41. Rovin J.D., Frierson H.F., Ledinh W., Parsons J.T., and Adams R.B. Expression of focal adhesion kinase in normal and pathologic human prostate tissues. Prostate 53 (2002) 124-132
42. Sawai H., Okada Y., Funahashi H., Matsuo Y., Takahashi Y., Takeyama H., and Manabe T. Activation of focal adhesion kinase enhances the adhesion and invasion of pancreatic cancer cells via extracellular signal-regulated kinase-1/2 signaling pathway activation. Mol. Cancer 4 (2005) 37
43. Schaller M.D., Hildebrand J.D., and Parsons J.T. Complex formation with focal adhesion kinase: a mechanism to regulate activity and subcellular localization of Src kinases. Mol. Biol. Cell 10 (1999) 3489-3505
44. Sonoda Y., Matsumoto Y., Funakoshi M., Yamamoto D., Hanks S.K., and Kasahara T. Anti-apoptotic role of focal adhesion kinase (FAK). Induction of inhibitor-of-apoptosis proteins and apoptosis suppression by the overexpression of FAK in a human leukemic cell line, HL-60. J. Biol. Chem. 275 (2000) 16309-16315
45. Sood A.K., Coffin J.E., Schneider G.B., Fletcher M.S., DeYoung B.R., Gruman L.M., Gershenson D.M., Schaller M.D., and Hendrix M.J. Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion. Am. J. Pathol. 165 (2004) 1087-1095
46. Theocharis S.E., Kouraklis G.P., Kakisis J.D., Kanelli H.G., Apostolakou F.E., Karatzas G.M., and Koutselinis A.S. Focal adhesion kinase expression is not a prognostic predictor in colon adenocarcinoma patients. Eur. J. Surg. Oncol. 29 (2003) 571-574
47. van Nimwegen M.J., Verkoeijen S., van Buren L., Burg D., and van de Water B. Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation. Cancer Res. 65 (2005) 4698-4706